Electroacupuncture at Baliao Points Alleviates Ulcerative Colitis via α7nAChR-Mediated Macrophage Polarization and Gut Microbiota Modulation.

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes significant discomfort and has limited treatment options. Researchers recently investigated whether electroacupuncture—a technique that applies mild electrical stimulation to acupuncture needles—could help manage this condition. They specifically studied stimulation at the Baliao points, a group of acupuncture points located on the lower back near the sacrum.

In this animal study using rats with induced colitis, electroacupuncture at the Baliao points produced significant improvements. The treatment reduced inflammation, restored normal colon length, and strengthened the intestinal barrier by increasing protective proteins that seal the gut lining. The researchers discovered how this works: the electrical stimulation activates specific nerve cells that release acetylcholine, a chemical messenger. This triggers a chain reaction through a receptor called alpha-7 nicotinic acetylcholine receptor (α7nAChR), which shifts immune cells called macrophages into an anti-inflammatory state. Additionally, the treatment restored healthy gut bacteria, increasing beneficial species like Lactobacillus while reducing harmful bacteria.

To confirm their findings, researchers blocked the α7nAChR receptor with a specific drug, which eliminated the beneficial effects of electroacupuncture. They also measured heart rate variability and found increased vagal nerve activity, suggesting the treatment works through the nervous system's anti-inflammatory pathways.

What this means for patients: This research suggests electroacupuncture may offer a promising alternative or complementary approach for managing ulcerative colitis by addressing the condition through multiple pathways—reducing inflammation, supporting gut barrier function, and promoting healthy microbiome balance. While these results are from animal studies and require human clinical trials for confirmation, they provide scientific support for electroacupuncture's potential therapeutic mechanisms. If considering electroacupuncture for inflammatory bowel conditions, consult with a licensed acupuncturist experienced in treating digestive disorders.

This preclinical study investigated electroacupuncture at Baliao acupoints (BL31-34) in a dextran sulfate sodium-induced ulcerative colitis rat model. EA treatment significantly ameliorated colitis symptoms, restored colon length, and enhanced intestinal barrier integrity through upregulation of tight junction proteins (ZO-1, occludin). Mechanistic analysis revealed EA activated cholinergic neurons in the dorsal root ganglion, elevated local acetylcholine levels, and increased α7nAChR-positive M2 macrophages in colonic tissue. Pharmacological blockade with methyllycaconitine (MLA), an α7nAChR antagonist, abolished therapeutic effects, confirming receptor-dependent mechanisms. Microbiome analysis demonstrated EA promoted beneficial bacteria (Lactobacillus) while suppressing pathogenic species. Heart rate variability assessment indicated enhanced parasympathetic activity post-treatment. Clinical implications: These findings provide mechanistic evidence for sacral electroacupuncture in inflammatory bowel disease management through neuroimmune modulation and microbiome restoration. The α7nAChR-dependent anti-inflammatory pathway represents a promising target for acupuncture-based IBD interventions, though human clinical trials are needed to translate these preclinical findings.